AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8781792
Drug: Endoscopic heat
RxNorm normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Endoscopic heat probe therapy (median 165 J) at 24 hours
Trial: 1627435
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with oral LMF (fluorouracil, 500 mg, methotrexate, 25 mg, and chlorambucil, 10 mg, on day 1; fluorouracil, 500 mg, and chlorambucil, 10 mg, on day 2)
Trial: 1627435
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with oral LMF
Trial: 6547563
Drug: Oestrogen/gestagen treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestrogen/gestagen treatment
Trial: 3532401
Drug: Chrysanol (calcium‐aurothiopropanol‐sulfonate)
RxNorm normalized name: dimethylmethoxy chromanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chrysanol (calcium‐aurothiopropanol‐sulfonate) plus nonsteroid antiinflammatory drugs (NAD)
Trial: 29369123
Drug: Tablet computer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet computer (intervention group)
Trial: 27950666
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy with TPF followed by concomitant CT/RT (Arm B)
Trial: 14974922
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment (33 microg/kg/day)
Trial: 14974922
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment (66 microg/kg/day)
Trial: 10826408
Drug: Diet 2:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet 2: L‐arginine enriched by natural foods
Trial: 10826408
Drug: Diet 3:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet 3: identical to Diet 1 plus oral L‐arginine supplement
Trial: 8649712
Drug: Once-daily gentamicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily gentamicin dosing (5 mg/kg)
Trial: 8649712
Drug: 8-hour gentamicin
RxNorm normalized name: gentamicin 0.8 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-hour gentamicin dosing (1.75 mg/kg every 8 hours)
Trial: 1341599
Drug: Nicotine polacrilex
RxNorm normalized name: Nicotine Polacrilex
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine polacrilex 0 mg (placebo)
Trial: 1341599
Drug: Nicotine polacrilex
RxNorm normalized name: Nicotine Polacrilex
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine polacrilex 2 mg
Trial: 1341599
Drug: Nicotine polacrilex
RxNorm normalized name: Nicotine Polacrilex
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine polacrilex 4 mg
Trial: 29952863
Drug: Repetitive transcranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repetitive transcranial magnetic stimulation (rTMS) delivered at 120% motor threshold, 10 Hz, 5-second train duration, and 10-second intertrain interval for 30 minutes weekly for 5 weeks (30,000 stimuli)
Trial: 27615005
Drug: Morning group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning group (MG, 9:00‐11:00 AM)
Trial: 18407386
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of MenC conjugate vaccine
Trial: 18407386
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses of MenC conjugate vaccine
Trial: 12365325
Drug: Immunocorrecting treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunocorrecting treatment with leukinferone
Trial: 12365325
Drug: Etiotropic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etiotropic therapy
Trial: 2644749
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml of glucose-free 2% lignocaine
Trial: 2644749
Drug: 3 ml
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 ml of glucose-free 2% lignocaine
Trial: 2644749
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml of glucose-free 2% lignocaine
Trial: 2644749
Drug: 3-4 ml
RxNorm normalized name: proline 3.4 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-4 ml of glucose-free 2% lignocaine
Trial: 2644749
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of glucose-free 2% lignocaine
Trial: 766574
Drug: practolol, 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: practolol, 15 mg
Trial: 31695330
Drug: Generic formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic formulation under fasting conditions
Trial: 31695330
Drug: Branded formulation
RxNorm normalized name: Eagle Brand Medicated Oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Branded formulation under fasting conditions
Trial: 31695330
Drug: Generic formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic formulation under fed conditions
Trial: 31695330
Drug: Branded formulation
RxNorm normalized name: Eagle Brand Medicated Oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Branded formulation under fed conditions
Trial: 31695330
Drug: Food intake
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Food intake before administration
Trial: 29998506
Drug: Post-HTx sST2
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-HTx sST2 levels ≥35 ng/mL (Group 2)
Trial: 29998506
Drug: Post-HTx sST2
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-HTx sST2 levels <35 ng/mL (Group 1)
Trial: 22079927
Drug: 10-mg hydrocortisone
RxNorm normalized name: hydrocortisone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mg hydrocortisone
Trial: 16633143
Drug: Reboxetine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine (8 mg/d)
Trial: 17513631
Drug: Propofol (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (1.5 microg/mL)
Trial: 11579243
Drug: Substituted protease
RxNorm normalized name: protease
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Substituted protease inhibitor(s) with abacavir, nevirapine, adefovir and hydroxyurea (n = 49)
Trial: 11579243
Drug: Continued all
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continued all therapy (n = 32)
Trial: 9360756
Drug: Cetirizine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine (10 mg OD)
Trial: 3319648
Drug: Glipizide treatment
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glipizide treatment for 8 weeks
Trial: 25330096
Drug: Agomelatine (single-dose)
DrugBank: Agomelatine (DB06594)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Agomelatine (single-dose)
Trial: 8071837
Drug: Placebo (single-dose)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (single-dose)
Trial: 20813349
Drug: Fluoride Gel
RxNorm normalized name: Sodium Fluoride Gel
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride Gel followed by no rinsing for 30 minutes
Trial: 20813349
Drug: Fluoride Gel
RxNorm normalized name: Sodium Fluoride Gel
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride Gel followed by rinsing with water
Trial: 10965647
Drug: 6-week treatment
RxNorm normalized name: Weeks and Leo Complete Lice Treatment KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-week treatment condition (applied relaxation and problem solving via the Internet and E-mail)
Trial: 29018885
Drug: Fasting Insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fasting Insulin
Trial: 25168918
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of influenza vaccination administered 5 weeks after standard vaccination
Trial: 25168918
Drug: Standard single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard single dose of influenza vaccination
Trial: 22402056
Drug: Rivaroxaban 20
RxNorm normalized name: rivaroxaban 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 20 mg daily
Trial: 22402056
Drug: Warfarin (adjusted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (adjusted dose, INR 2.0-3.0)
Trial: 20639824
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium 0.1% eye drop - 1 drop 4 times daily for 30 days after cataract surgery
Trial: 20639824
Drug: Prednisolone acetate
RxNorm normalized name: Prednisolone Acetate
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone acetate 1% eye drop - 1 drop 2 hourly for 1 week, then 1 drop 4 hourly for 2 weeks, then 1 drop 6 hourly for 30 days after cataract surgery
Trial: 9506325
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blockers (in SAVE placebo group)
Trial: 9506325
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blockers (in SAVE captopril group)
Trial: 7918923
Drug: Pentasa 2
RxNorm normalized name: Pentasa 250mg Extended-Release Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentasa 2 g/day
Trial: 15118975
Drug: Pentasa 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentasa 4 g/day
Trial: 7918923
Drug: Pentasa 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentasa 6 g/day
Trial: 7918923
Drug: Olsalazine 2
RxNorm normalized name: olsalazine 250 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olsalazine 2 g/day
Trial: 7918923
Drug: Pentasa 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentasa 4 g/day and 6 g/day
Trial: 28875327
Drug: 200-μg selenium
RxNorm normalized name: SELENIUM 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200-μg selenium per day for 8 weeks
Trial: 28390695
Drug: Oral ramipril
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ramipril 10 mg/day (n=8407)
Trial: 28390695
Drug: Oral telmisartan
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral telmisartan 80 mg/day (n=8386)
Trial: 28390695
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ramipril and telmisartan (n=8334)
Trial: 28390695
Drug: Oral telmisartan
RxNorm normalized name: Telmisartan
DrugBank: Telmisartan (DB00966)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral telmisartan 80 mg/day (n=2903)
Trial: 10590490
Drug: Beta-blockers (e.g.,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (e.g., carvedilol)
Trial: 10590490
Drug: EP guided
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EP guided therapy
Trial: 1605660
Drug: Norfloxacin (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin (800 mg, orally QID)
Trial: 6374774
Drug: etidocaine 1.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: etidocaine 1.5% with ornipressine 1 IU/10 ml (n = 10)
Trial: 27503474
Drug: Typhoid polysaccharide
RxNorm normalized name: Typhoid polysaccharide vaccine in parenteral dose form
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typhoid polysaccharide vaccine
Trial: 25252510
Drug: Eutectic Mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eutectic Mixture of Local Anaesthetics cream (2g applied to injection site)
Trial: 25252510
Drug: Rattle (shaken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rattle (shaken for 30s to 15s before injection)
Trial: 25252510
Drug: Eutectic Mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eutectic Mixture of Local Anaesthetics cream
Trial: 20876734
Drug: NT-proBNP guided
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NT-proBNP guided therapy
Trial: 20876734
Drug: Guideline-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline-based treatment
Trial: 10027027
Drug: Dixyrazine 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dixyrazine 0.25 mg kg‐1
Trial: 7015021
Drug: Minidose propranolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minidose propranolol (5 to 10 mg/6 hr)
Trial: 7015021
Drug: Propranolol postoperatively
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol postoperatively (not specified dosage)
Trial: 26378246
Drug: Caffeine (dose-dependent)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (dose-dependent)
Trial: 22879443
Drug: Manual therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy and spine strengthening exercises
Trial: 17130429
Drug: Carbamazepine as
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine as monotherapy
Trial: 17130429
Drug: Valproate as
RxNorm normalized name: valproate
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproate as monotherapy
Trial: 17130429
Drug: Delayed antiepileptic
RxNorm normalized name: ANTIEPILEPTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed antiepileptic drug treatment
Trial: 9292072
Drug: Solution vehicles
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution vehicles and empty chamber
Trial: 3518596
Drug: Fluoxymesterone (synthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxymesterone (synthetic androgen) for 3 days before and on the day of chemotherapy
Trial: 3518596
Drug: Cyclic chemotherapy
RxNorm normalized name: cyclic AMP
DrugBank: Cyclic adenosine monophosphate (DB02527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclic chemotherapy with aminoglutethimide and hydrocortisone
Trial: 22520267
Drug: Dose to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose to the anal surface at 53 Gy
Trial: 22520267
Drug: Mean dose
RxNorm normalized name: OCTINOXATE 5 mg in 100 mL / AVOBENZONE 3 mg in 100 mL TOPICAL LOTION [Meaningful Beauty Cindy Crawford Maintenance 1 Daily Moisture SPF 8]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mean dose to the anal surface
Trial: 19669773
Drug: Intracorporeal pneumatic
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracorporeal pneumatic shock therapy (IPST)
Trial: 12227275
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (Verteporfin)
Trial: 8550248
Drug: CoQ10 (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CoQ10 (150 mg/day for 2 months)
Trial: 2693917
Drug: Transdermal 17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17 beta-estradiol (Estraderm)
Trial: 31880370
Drug: Kisspeptin-10 (Kp10)
RxNorm normalized name: Kisspeptin-10
DrugBank: Kisspeptin-10 (DB16210)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kisspeptin-10 (Kp10) injection (5 µg/kg body weight), administered intramuscularly once a week for 1 month
Trial: 30935545
Drug: Propolis (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propolis (500 mg, three times a day for 8 weeks)
Trial: 29145288
Drug: Cold application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold application (600-g ice packs for 15 minutes before CTR)
Trial: 29145288
Drug: Sham treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham treatment (tap water packs)
Trial: 23053900
Drug: Mosapride (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mosapride (30 mg) plus esomeprazole (40 mg)
Trial: 23053900
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus esomeprazole (40 mg)
Trial: 18752430
Drug: Hepatitis A
RxNorm normalized name: HEPATITIS A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis A virus (HAV) vaccine
Trial: 18752430
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (received TT vaccine first, then HAV vaccine)
Trial: 7529468
Drug: Large-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Large-dose aprotinin (initial dose of 2,000,000 KIU followed by infusion of 500,000 KIU/h)
Trial: 7529468
Drug: Small-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Small-dose aprotinin (initial dose of 500,000 KIU followed by infusion of 150,000 KIU/h)
Trial: 28712353
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) intervention for PTSD (CBT-P), 12-16 sessions
Trial: 22237990
Drug: Seating force
RxNorm normalized name: Clean Force
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Seating force of 10 g
Trial: 22237990
Drug: Seating force
RxNorm normalized name: Clean Force
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Seating force of 50 g
Trial: 22237990
Drug: Seating force
RxNorm normalized name: Clean Force
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Seating force of 100 g
Trial: 22237990
Drug: Seating force
RxNorm normalized name: Clean Force
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Seating force of 500 g
Trial: 22237990
Drug: Seating force
RxNorm normalized name: Clean Force
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Seating force of 750 g
Trial: 21671496
Drug: Bismuth-based quadruple
RxNorm normalized name: bismuth
DrugBank: Bismuth cation (DB14572)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth-based quadruple therapy (esomeprazole 20 mg, clarithromycin 0.5 g, amoxicillin 1.0 g, bismuth potassium citrate 220 mg for 7 days)
Trial: 21671496
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy (esomeprazole 20 mg, clarithromycin 0.5 g, amoxicillin 1.0 g for 7 days)
Trial: 19086083
Drug: Early-start rasagiline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early-start rasagiline treatment
Trial: 19086083
Drug: Delayed-start rasagiline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed-start rasagiline treatment (placebo for 6 months)
Trial: 12077522
Drug: 20% azelaic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% azelaic acid formulation
Trial: 12077522
Drug: Topical whitening
RxNorm normalized name: monofluorophosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical whitening agents
Trial: 10465378
Drug: Transdermal gel
RxNorm normalized name: Androgel 1% Transdermal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal gel (1.5 mg oestradiol)
Trial: 10465378
Drug: Tablet (2
RxNorm normalized name: VOYDEYA Tablet (200mg Dose)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet (2 mg oestradiol valerate)
Trial: 475944
Drug: Hyoscine hydrobromide
RxNorm normalized name: Hyoscine hydrobromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine hydrobromide (0.3 mg)
Trial: 25251893
Drug: Midazolam-meperidine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam-meperidine combination (group-MM)
Trial: 23782589
Drug: 6 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g/day of fish oil (approximately 3.6 g/day of LCn‐3PUFA)
Trial: 23782589
Drug: 6 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g/day of corn oil (placebo)
Trial: 19207321
Drug: Fanning injection
RxNorm normalized name: chlorpheniramine tannate Oral Tablet [Ed Chlor Tan]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fanning injection technique
Trial: 17161821
Drug: FTY720 (0.25-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTY720 (0.25-2 mg)
Trial: 17161821
Drug: FTY720 (3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTY720 (3.5 mg)
Trial: 9920537
Drug: Norgestimate and
RxNorm normalized name: norgestimate and estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norgestimate and ethinyl estradiol (0.035 mg ethinyl estradiol plus increasing doses of norgestimate [0.180 mg, 0.215 mg, 0.250 mg]) for 3 weeks followed by 1 week of inactive tablets
Trial: 9920537
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets for 4 weeks
Trial: 2972549
Drug: Cetirizine di-HCl
RxNorm normalized name: LEVOCETIRIZINE DI-HCL 2.5MG/5ML ORAL SOL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine di-HCl (10 mg)